Jason Hoitt - Chief Patient Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Patient Officer
Issuer Symbol
STOK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Hoitt since 06 Mar 2025

Holdings reported by Jason Hoitt for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,802 $17,533 $9.73 18 Jun 2025 Direct
Employee Stock Option (Right to Buy) 72,000 17 Feb 2026 Direct Common Stock
Restricted Stock Units 48,000 17 Feb 2026 Direct Common Stock

Transactions reported by Jason Hoitt for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.